Federal Judge Nears Approval of Purdue Pharma Opioid Settlement, Sackler Family to Pay Billions
A federal judge is nearing approval of Purdue Pharma's opioid settlement, requiring the Sackler family to pay billions and allocating $850 million to victims, including $100 million for affected children.
Overview
- A federal bankruptcy court judge is close to approving Purdue Pharma's settlement deal, resolving numerous lawsuits related to its role in the widespread opioid epidemic.
- The comprehensive agreement mandates the Sackler family to contribute up to $7 billion and relinquish ownership of Purdue Pharma, addressing their accountability in the crisis.
- The settlement allocates approximately $850 million to individual victims affected by the opioid crisis, providing crucial financial relief and support.
- Notably, over $100 million from the settlement is specifically designated to assist children born with opioid withdrawal symptoms, addressing their unique needs.
- With government groups largely in consensus and only subdued opposition, this approval is set to finalize the extensive resolution of the opioid litigation.
Report issue
Read both sides in 5 minutes each day
Analysis
Center-leaning sources cover this story neutrally, focusing on the factual details of the Purdue Pharma settlement. They present the terms of the deal, including the Sackler family's contributions and the company's restructuring, without injecting editorial judgment. The reporting prioritizes clarity and comprehensive information regarding the legal outcomes and financial implications for victims.
"The plan also calls for changing Stamford, Connecticut-based Purdue's name to Knoa Pharma and making it an entity dedicated to the public good with a board appointed by state officials."
ABC News"Purdue’s deal calls for about $850 million to go to victims, with more than $100 million of that dedicated to the care of children who were born suffering from withdrawal."
Associated Press"The deal overseen by U.S. Bankruptcy Judge Sean Lane would require members of the Sackler family who own the company to contribute up to $7 billion over 15 years."
NPRArticles (6)
Center (3)
FAQ
The Sackler family is required to pay up to $7 billion as part of the Purdue Pharma opioid settlement.
Approximately $850 million is allocated to individual victims, with over $100 million specifically designated for children born with opioid withdrawal symptoms.
The Sackler family will relinquish ownership of Purdue Pharma as part of their accountability in the opioid crisis under the settlement agreement.
Government groups are largely in consensus supporting the settlement, with only subdued opposition, which is facilitating the finalization of the opioid litigation resolution.
Settlement funds allocated to city and county governments must be spent on opioid remediation efforts to address and abate the opioid crisis in their communities.
History
- 23d
3 articles